Benzinga's Top #PreMarket Losers

by Monica Gerson, Benzinga Staff Writer

March 31, 2015 8:21 AM | 1 min read | Make a Comment

Synta Pharmaceuticals Corp. SNTA

shares declined 16.74% to $1.94 in pre-market trading. Synta Pharmaceuticals launched a public offering of its shares.

Celladon Corporation CLDN

fell 6.23% to $20.32 in pre-market trading. Celladon reported a Q4 consolidated loss of $11.34 million.

Insmed Incorporated INSM

slipped 3.89% to $20.27 in pre-market trading after the company announced a public offering of 10 million shares of common stock.

Lorillard, Inc.LO

shares dropped 2.15% to $64.99 in pre-market following the NY Post report FTC has recommended a lawsuit to block merger of Reynolds American and Lorillard.

Reynolds American Inc. RAI

shares fell 2.12% to $68.00 in pre-market trading following the NY Post report FTC has recommended a lawsuit to block merger of Reynolds American and Lorillard.

Market News and Data brought to you by Benzinga APIs

Posted In: News Movers & Shakers Pre-Market Outlook Markets Consumer Staples Tobacco Top Losers

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!